Serious dengue in a woman with previous infection due to SARS-CoV-2
Keywords:
, coronavirus infections, SARS virus, dengue, secondary health care.Abstract
The case report of a 30 years patient with history of bronchial asthma, gastroduodenal ulcer and hepatitis C virus is presented. She was admitted to Dr. Ambrosio Grillo Portuondo Clinical-Surgical University Hospital in Santiago de Cuba in 2 occasions: first for presenting SARS-CoV-2 infection and then, dengue virus, with serious forms of the disease in both moments, reason why it is deduced that the vascular damage caused by SARS-CoV-2 can be a risk factor so that dengue with warning signs is developed.
Downloads
References
2. Organización Mundial de la Salud; Organización Panamericana de la Salud. Dengue y dengue grave. Washington, D.C.: OPS; 2023 [citado 22/01/2023]. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/dengue-and-severe-dengue
3. Organización Panamericana de la Salud; Organización Mundial de la Salud. Dengue. Washington, D.C.: OPS; 2023 [citado 22/01/2023]. Disponible en: https://www.paho.org/es/temas/dengue
4. Portal Miranda JA. Dengue: identificar sus fases y signos de alarma, salva vidas. La Habana: MINSAP; 2022 [citado 22/01/2023]. Disponible en: https://salud.msp.gob.cu/dengue-identificar-sus-fases-y-signos-de-alarma-salva-vidas/
5. Centro para el Control y la Prevención de Enfermedades. Dengue. Cuadro clínico, Washington, D.C.: U.S. Department of Health and Human Services; 2023. [citado 22/01/2023]. Disponible en: https://www.cdc.gov/dengue/es/healthcare-providers/clinical-presentation.html
6. Martínez Torres E, Sabatier García J. Dengue y COVID-19: semejanzas y diferencias. Rev Cuban Pediatr. 2020 [citado 22/01/2023];92( Suppl 1 ):e1211. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312020000500026
7. Moctezuma Paz A, Flores Legorreta JP, Benítez González GA, Solís Chávez PC. Dengue en tiempos de COVID-19. Rev Med Inst Mex Seguro Soc. 2021 [citado 22/01/2023];59(6):463-4. Disponible en: https://docs.bvsalud.org/biblioref/2022/01/1353329/rm2021-6-01-4428-editorial.pdf
8. Organización Panamericana de la Salud; Organización Mundial de la Salud. Actualización epidemiológica. Arbovirosis en el contexto de COVID-19. Washington, D.C.: OPS; 2021. p. 12 [citado 22/01/2023]. Disponible en: https://www.paho.org/es/documentos/actualizacion-epidemiologica-arbovirosis-contexto-covid-19-2-julio-2021
9. Goshua G, Pine AB, Meizlish ML, Chang CH, Zhang H, Bahel P, et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020 [citado 30/06/2022];7(08):e575–82. Disponible en: https://www.sciencedirect.com/science/article/pii/S2352302620302167?via%3Dihub
10. León Ramentol C, Betancourt Bethencourt JA, Nicolau Pestana E, Torres Téllez K. Biomarcadores para la predicción de la gravedad del dengue. Correo Cient Méd. 2016 [citado 03/02/2023];20(2):305-21. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1560-43812016000200008
Published
How to Cite
Issue
Section
License
All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.
![Secimed](/templates/images/secimed.png"){kind=small}
Guidelines for authors
